Epidermolysis Bullosa: Types, Symptoms, Diagnosis, and Care

Epidermolysis bullosa (EB) describes a group of conditions that make skin fragile, so blisters and wounds can form after minor friction or injury. The inherited types differ in the skin layer and protein affected. Symptoms range from a few blisters to more complex skin, mouth, nutrition, movement, or wound-healing problems.

Medical information: This educational guide cannot diagnose EB or replace care from an experienced clinician. Newborns with unexplained blisters and anyone with worsening wounds, infection signs, or difficulty swallowing or breathing need prompt medical assessment.

What epidermolysis bullosa is

Epidermolysis bullosa (EB) is a group of rare conditions in which the skin is unusually fragile and blisters or tears more easily than expected. In inherited EB, gene changes affect proteins that help hold the layers of skin together. A small amount of friction, pressure, warmth, or everyday movement can then injure the skin. The exact pattern and severity depend on the subtype and the gene involved.

Most inherited forms show signs at birth or in infancy, but a mild form may not become apparent until a baby begins crawling or walking and friction increases. EB affects people of all backgrounds and can vary from a few recurring blisters on the hands and feet to widespread skin and mucosal disease with scarring and medical complications. A person's needs can change with age, growth, activity, and wound burden.

This guide focuses mainly on inherited EB. Epidermolysis bullosa acquisita (EBA) is a separate, uncommon autoimmune disease in which antibodies attack a skin anchoring protein. EBA is not inherited in the same way as the main EB types and can begin later in life. A specialist distinguishes it from inherited EB because diagnosis and treatment are different.

How fragile skin affects daily life

Blisters can form where shoes, clothing, diapers, medical equipment, or skin folds rub. Some people also blister after heat, sweating, or pressure. When a blister breaks, it leaves a raw wound that may be painful and slow to heal. Healing can leave changes in pigment, small white bumps called milia, or scar tissue, depending on the type and depth of the injury.

EB can affect the mouth and other moist linings. Blisters in the mouth may make brushing, eating, or drinking difficult. In more involved subtypes, the esophagus, eyes, airway, bowel, urinary tract, or genital skin may also be affected. Not every person has these problems; the likely concerns depend on the subtype.

Care itself can be difficult. Removing a dressing, bathing, walking, or changing clothes may cause pain or new skin injury. Families often need to learn safe wound care and adapt routines. A coordinated plan can reduce avoidable friction while still supporting movement, school, work, play, and independence.

The main inherited types

Doctors classify inherited EB partly by the level in the skin where separation occurs and partly by the gene change. Epidermolysis bullosa simplex (EBS) involves separation within the epidermis, the skin's outer layer. It is the most common major type. Milder forms often cause blisters on the palms and soles; other forms can affect more body areas. Heat, sweating, or friction may influence symptoms in some people.

Junctional epidermolysis bullosa (JEB) involves the junction between the epidermis and the deeper dermis. Its severity varies. Some forms can cause widespread wounds and involve the mouth, esophagus, airway, or other mucosal surfaces. Depending on subtype, people may also need support for dental enamel, nutrition, anemia, growth, nails, or hair.

Dystrophic epidermolysis bullosa (DEB) involves a deeper skin layer and is linked to problems with type VII collagen, which helps anchor the skin layers. Dominant and recessive forms differ. Repeated blistering can lead to scarring, nail loss, tightness, and in some people fusion of fingers or toes. Severe recessive DEB can affect swallowing, nutrition, growth, eyes, teeth, and other systems and carries an increased risk of aggressive squamous cell skin cancer.

Kindler syndrome is a less common inherited type in which skin separation can occur at more than one level. It may include blistering, photosensitivity, skin thinning or color change, scarring, and mucosal involvement. There are many additional subtypes within the major groups, so a broad label alone does not predict a person's course.

Genes and inheritance

Most inherited EB is caused by a pathogenic variant in a gene that provides instructions for a structural protein in the skin. In different subtypes, the affected protein may help connect skin cells to one another or anchor the epidermis to deeper layers. When the protein is absent, altered, or made in reduced amounts, the skin is less resistant to friction and trauma.

Some EB types are inherited in an autosomal dominant pattern, meaning a single altered copy of a gene can cause the condition. Others are inherited in an autosomal recessive pattern, usually requiring altered copies from both parents. The exact pattern depends on the subtype and gene. A parent can carry a recessive variant without having EB symptoms.

A genetic counselor can review family history, test results, and the chance of passing a variant to children. Genetic counseling is also helpful for people planning a pregnancy or trying to understand why relatives have different symptoms. Prenatal or reproductive testing may be available in some settings, but the options depend on the identified genetic variant and local services.

EB is not caused by a parent's actions during pregnancy, poor hygiene, or contact with another person. The non-inherited condition EBA results from an immune attack on skin anchoring proteins and should not be confused with genetic EB.

Symptoms and possible complications

Common signs include blisters after minor injury, raw wounds, pain, itch, and slow healing. Nails may become thick, misshapen, or lost. Scalp blistering can cause scarring hair loss. Some people develop milia or changes in skin color. The pattern can be limited to pressure areas or affect much of the body, depending on the type.

Repeated wounds and scarring may tighten the skin, tendons, or joints. In severe DEB, fingers or toes can gradually fuse, a process sometimes called mitten deformity. Contractures can limit movement and hand function. Physical and occupational therapy can support safe movement and adaptations without ignoring the need to protect fragile skin.

Mouth and esophageal involvement can make eating or swallowing painful. A person may avoid food, become constipated, or have difficulty maintaining weight. Wounds can cause fluid loss, infection, and anemia. Dental enamel or gum problems may require an experienced dentist. Eye involvement can cause irritation or injury to the cornea, and airway or throat disease can affect breathing or voice.

People with severe recessive DEB have a substantially increased risk of squamous cell skin cancer, which may grow more aggressively than usual. Any persistent, changing, thickened, or non-healing wound needs prompt review by the EB team. Scheduled skin surveillance is important in subtypes with higher cancer risk.

How specialists confirm a diagnosis

Diagnosis starts with a detailed examination of the skin and, when appropriate, the mouth or other affected surfaces. The clinician asks when blistering began, what triggers it, how wounds heal, which areas are affected, and whether relatives have similar symptoms. A family history can be helpful, but some families have no previously diagnosed member.

Specialized testing is usually needed to confirm EB and identify its type. A skin biopsy may be examined with microscopy or other laboratory methods to determine where the skin separates and which proteins are present. Genetic testing can identify a disease-causing variant and refine the subtype. The choice and order of tests depend on age, symptoms, and the local specialist service.

Testing helps the care team anticipate complications and decide what follow-up is needed. It can also inform genetic counseling. Some people need additional assessments of nutrition, blood counts, dental health, eyes, swallowing, movement, or cancer risk. These checks are chosen according to the subtype and symptoms rather than being required for everyone.

A diagnosis of EBA may involve tests for autoantibodies and a different interpretation of biopsy findings. If blistering begins in adulthood without a childhood history, the clinician considers both inherited and acquired causes. Getting the distinction right matters because the care plan differs.

Wound care and skin protection

Wound care should be taught by a clinician experienced with EB. The team can recommend dressings that are less likely to stick, how to secure them without irritating skin, and how often to change them. Adhesive tapes can tear fragile skin when removed, so the care plan may use non-adhesive products or another secure method. The right approach differs by wound, body site, and EB type.

Do not puncture, drain, or cut a blister unless the EB team has shown you what to do and advised it for that person. Some teams may recommend controlled drainage while leaving the blister roof in place, but the plan should be individualized. If a dressing sticks, the clinician may suggest soaking it to release it rather than pulling. Avoid using strong antiseptics, antibiotic creams, or household remedies unless they are part of the written care plan.

Clean hands and clean supplies reduce the chance of introducing germs during dressing changes. The team can show family members, school staff, or caregivers how to handle a child or adult gently and how to recognize infection. If a wound becomes more painful, red, warm, swollen, or produces pus, or if fever develops, contact the care team promptly.

Comfortable clothing, soft seams, padding over pressure points, and well-fitting footwear can reduce rubbing. Keep the skin from overheating when this triggers blisters. A clinician or occupational therapist can advise on cushions, wheelchairs, braces, or adaptive clothing. The goal is to reduce preventable skin injury while allowing people to move and take part in daily life.

Pain, itch, nutrition, and mobility

Pain may come from blisters, open wounds, infection, bathing, dressing changes, movement, or swallowing. The care team can discuss pain relief before dressing changes and options for persistent pain. Itch can lead to scratching and further skin injury, so ask about safe ways to control it rather than trying multiple over-the-counter creams without guidance.

Nutrition matters because wound healing uses energy and protein. People with extensive wounds or mouth and esophageal involvement may need help maintaining fluids, calories, iron, vitamins, and growth. A dietitian can suggest soft, nutrient-dense foods or supplements tailored to swallowing and bowel symptoms. A new difficulty swallowing, persistent constipation, or unplanned weight loss should be shared with the EB team.

Physical and occupational therapy can help maintain movement, preserve joint function, and adapt daily tasks. Therapists familiar with EB can recommend ways to exercise while limiting friction and pressure. Protective care should not become unnecessary restriction: safe movement supports strength, participation, and independence.

Support for mental health and family routines is also part of care. A visible or painful chronic condition can affect sleep, relationships, school, employment, and confidence. Social work, counseling, patient organizations, or respite support may help families and adults manage long-term care.

Treatments for wounds and ongoing care

There is no single treatment that prevents every blister or cures all inherited forms of EB. Care aims to reduce friction, protect and heal wounds, manage pain and itch, prevent infection, maintain nutrition and movement, and detect complications early. Treatment is individualized and may involve a specialized EB center with dermatology, nursing, nutrition, dentistry, ophthalmology, pain care, and rehabilitation.

In the United States, several wound-directed treatments are approved for specific EB types. Vyjuvek (beremagene geperpavec-svdt) is a topical gene therapy indicated for wounds in adults and children with dystrophic EB linked to COL7A1 gene mutations. It delivers a functional copy of the gene to selected wounds; the care team decides which wounds are appropriate and how it is used.

Filsuvez is a topical gel made with birch triterpenes and is approved for wounds associated with dystrophic or junctional EB in adults and children aged six months and older in the United States. Zevaskyn is an autologous cell-sheet-based gene therapy approved for wounds in adults and children with recessive dystrophic EB. It uses a patient's own modified skin cells and is delivered as a medical procedure.

These treatments are specific to particular wound indications and subtypes; they do not remove every symptom or replace wound care. Eligibility, delivery, risks, access, and regulatory approval vary by product and country. A specialist can explain whether a treatment fits the person's genetic diagnosis and wound pattern. Do not apply a prescription or specialized product without the care team's instructions.

Depending on complications, the team may also treat anemia, infection, esophageal narrowing, contractures, eye disease, dental problems, or skin cancer. Procedures may be considered for selected problems such as a narrowed esophagus or fused digits. The risks and expected benefit depend on the subtype and wound healing capacity.

Monitoring and urgent warning signs

Follow-up depends on EB type and severity. It can include wound review, growth and nutrition checks, mobility assessment, dental visits, blood tests, eye review, and skin cancer surveillance. A written care plan helps coordinate the family, school, clinicians, and other caregivers. Ask who to contact during a flare and which local service is familiar with EB.

Seek prompt medical advice for increasing redness, warmth, swelling, pain, pus, red streaks, or fever around a wound. Large open areas can lead to dehydration; reduced urination, unusual sleepiness, dizziness, or inability to drink are concerning. Worsening anemia, persistent weight loss, or a wound that does not heal also needs assessment.

Breathing difficulty, a new hoarse or weak cry in an infant, choking, inability to swallow fluids, severe eye pain, light sensitivity, or vision change needs urgent medical review. Use emergency services for severe breathing difficulty or another immediate emergency. Do not wait for a routine appointment if the person is deteriorating.

For people with severe DEB, arrange prompt review of a wound that changes, thickens, bleeds repeatedly, or remains open. The clinician may examine it and decide whether a biopsy is needed. Early assessment helps distinguish a difficult EB wound from infection or skin cancer.

Questions to discuss with the EB team

Ask which EB subtype and gene change have been identified, what that means for the person's likely complications, and whether genetic counseling is appropriate. Ask which dressings and products are safe, how to handle blisters, and what to do if a dressing sticks. A written wound-care plan is useful for home, travel, school, or work.

Ask how often to review nutrition, anemia, dental health, eyes, movement, and skin cancer risk. If wound-directed gene or cell therapy is available in your region, ask whether the person's type and wound meet the approved indication, what the procedure involves, and what care continues afterward.

Discuss pain and itch openly, including pain during dressing changes and activities being avoided. Ask which symptoms need same-day advice, where to go after hours, and whether a local or regional EB center can coordinate care. The best plan is one that protects skin while supporting daily life.

Key takeaways

Epidermolysis bullosa is a group of skin-fragility conditions, most often inherited, that can cause blisters after minor friction or injury. The major types differ in the skin layer and protein affected, so symptoms and complications vary widely. Diagnosis uses specialist assessment, skin testing, and often genetic testing. Care centers on wound protection, pain and itch control, infection prevention, nutrition, mobility, and screening for complications. Some wound-directed therapies are approved for selected subtypes, but care remains individualized and ongoing.

Frequently asked questions

Sources and further reading

These dermatology, genetics, and regulatory resources informed this overview. Treatment availability and product labels vary by location; a specialist can advise on an individual case.

• NIAMS: Epidermolysis bullosa types, symptoms, and causes
• NIAMS: Epidermolysis bullosa diagnosis, treatment, and steps to take
• American Academy of Dermatology: EB diagnosis and treatment
• AAD: EB signs and symptoms
• FDA: Vyjuvek
• FDA: Zevaskyn
• FDA: Filsuvez

Editorial note: FDA-approved wound-directed therapies apply to specific EB types and indications. They do not replace individualized wound care or specialist follow-up.